Lucy Anderson
Senior Consultant
About
Lucy is a senior consultant in our Corporate department. She has over 25 years of experience, including over 18 years advising on corporate, M&A and investment funds matters in relation to Cayman Islands law.
Lucy’s practice centres on emerging and high-growth companies across a variety of industries, including technology and life sciences. She advises on the full spectrum of corporate transactions, including the establishment of holding structures, preferred equity financings, strategic investments, employee incentive arrangements, restructurings, M&A, as well as IPOs on NASDAQ and the Hong Kong Stock Exchange (HKEX).
Lucy also acts for fund sponsors and has significant experience in the formation and ongoing operation of private equity funds, venture capital funds and hedge funds.
Experience
- Corporate
- Mergers and acquisitions
- Joint ventures
- Equity capital markets
- Venture capital
- Private equity
- Hedge funds
-
Work highlights
- Advised Structure Therapeutics Inc. (NASDAQ: GPCR) on its US$547 million IPO, a further US$650 million public offering of ADSs and pre-funded warrants, and its US$250 million at-the-market offering
- Advised ProfoundBio Inc. on its US$1.8 billion acquisition by Genmab A/S (NASDAQ: GMAB)
- Advised VISEN Pharmaceuticals (HKEX: 2561) on its HK$783 million (approx. US$100 million) IPO
-
Qualifications and admissions
- Attorney-at-Law of the Cayman Islands, 2008
- Legal practitioner of the Supreme Court of New South Wales and the High Court of Australia, 1998 (non-practising)
- Master of Business Administration, Macquarie University, 2004
- Bachelor of Laws (Honours), Australian National University, 1998
- Bachelor of Arts (philosophy), Australian National University, 1994
-
Publications and news
